Cell-Free Fetal DNA in the Maternal Circulation and its Future Uses in Obstetrics

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 1, 2005, Pages 54-57

  Wilson, R Douglas ^a   Gagnon, Alain ^a   Gregory Davies, ^a   Desilets, Valerie ^a   Reid, Gregory J ^a   Summers, Anne ^a   Wyatt, Philip ^a   Allen, Victoria ^a   Langlois, Sylvie ^a  

^a NONE   (Canada)

Author keywords

Cell free fetal DNA; Maternal plasma; Maternal serum; Obstetrical complications; Prenatal diagnosis; Screening

Indexed keywords

C REACTIVE PROTEIN; CELL FREE FETAL DNA; DNA; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BETA THALASSEMIA; BLOOD LEVEL; CELL FREE SYSTEM; DNA MARKER; FETUS DISEASE; HELLP SYNDROME; HUMAN; MATERNAL PLASMA; NON INVASIVE PROCEDURE; OBSTETRICS; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; SENSITIVITY AND SPECIFICITY; SEX DETERMINATION; TRISOMY 13; TRISOMY 21; X CHROMOSOME LINKED DISORDER; BLOOD; CHROMOSOME ABERRATION; FEMALE; FETUS; GENETICS; METHODOLOGY; PREGNANCY COMPLICATION; REVIEW;

CHROMOSOME ABERRATIONS; DNA; FEMALE; FETAL DISEASES; FETUS; HUMANS; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL DIAGNOSIS;

EID: 21744454518     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30173-6     Document Type: Article

References (31)

1. Chan AK, Chiù RW, Lo YM Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem 2003, 40(Pt 2):122-130.
2. Lo YM. Circulating nucleic acids in plasma and serum: an overview. Ann NY Acad Sci 2001, 945:1-7.
3. Chiù RW, Lo YM. Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis. Expert Rev Mol Diagn 2002, 2(1):32-40.
4. Chiù RW, Lo YM. Non-invasive prenatal diagnosis: on the horizon?. Pharmacogenomics 2003, 4(2):191-200.
5. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350(9076):485-487.
6. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62(4):768-775.
7. Jackson L Fetal cells and DNA in maternal blood. Prenat Diagn 2003, 23:837-936.
8. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998, 339:1734-1738.
9. Rijnders RJP, Christiaens GC, Bossers B, van der Smagt JJ, van der Schoot CE, de Haas M. Clinical applications of cell-free fetal DNA from maternal plasma. Obstet Gynecol 2004, 103:157-164.
10. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders [letter]. N Engl J Med 2002, 346:1502.
11. Chiù RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM. Prenatal exclusion of beta thalassemia major by examination of maternal plasma. Lancet 2002, 360(9338):998-1000.
12. Chiù RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002, 48(5):778-780.
13. Ding C, Chiù RWK, Lau TK, Leung TN, Chan LC, Chan AYY, et al. Non-invasive prenatal diagnosis of B-thalassemia by mass spectrometric analysis of fetal DNA in maternal plasma. Am J Hum Genet 2003, 73(5):189.
14. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002, 48(12):2141-2146.
15. Farina A, Sekizawa A, Sugito Y, Iwasaki M, Jimbo M, Saito H, et al. Fetal DNA in maternal plasma as a screening variable for preeclampsia: a preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients. Prenat Diagn 2004, 24:83-86.
16. Levine RJ, Qian C, LeShane ES, Yu KF, England LJ, Schisterman EF, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004, 190:707-713.
17. Driscoll DA, Wenstrom KD, Williams J ACOG Committee on Genetics. Genetics and molecular diagnostic testing. ACOG Technology Assessment in Obstetrics and Gynecology. Obstet Gynecol 2002, 100(1):193-208.
18. Rijnders RJP, Van Der Luigt RB, Peters EDJ, Goeree JK, Van Der Schoot CE, Ploos Van Amstel JK, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003, 23:1042-1044.
19. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002, 22(10):946-948.
20. Amicucci P, Gennarelli M, Novelli G, Dallapicolla B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000, 46:301-302.
21. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T., Prenatal DNA diagnosis of a single gene disorder from maternal plasma. Lancet 2000, 356:1170.
22. Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW, et al. Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol 2002, 187(5):1217-1221.
23. Wataganara T, LeShane ES, Farina A, Messerlian GM, Lee T, Canick JA, et al. Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18. Hum Genet 2003, 112(2):204-208.
24. Farina A, LeShane ES, Lambert-Messerlian GM, Canick JA, Lee T Palomaki Gè, et al. Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem 2003, 49(2):239-242.
25. Bischoff FZ, Dang D, Home C, Marquez-Do D, Brinkley WR, Lewis DE, et al. Fetal DNA in maternal plasma circulates as apoptotic bodies: elucidation of the structural nature of fetal DNA for non-invasive prenatal genetic diagnosis. Am J Hum Genet 2003, 73(5):189.
26. Ng EK, Tsui NB, Lau TK, Leung TN, Chiù RW, Panesar NS, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Nad Acad Sci 2003, 100(8):4748-4753.
27. Poon LL, Leung TN, Lau TK, Lo YM. Circulating fetal RNA in maternal plasma. Ann NY Acad Sci 2001, 945:207-210.
28. Sekizawa A, Sugito Y, Iwasaki M, Watanabe A, Jimbo M, Hoshi S, et al. Cell-free fetal DNA is increased in plasma of women with hyperemesis gravidarum. Clin Chem 2001, 47(12):2164-2165.
29. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002, 48(2):353-354.
30. Swinkels DW, de KokJB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002, 48(4):650-653.
31. Lo Y, Zhang J, Leung TN, Lau TK, Chang AMZ, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999, 64:218-224.